Baird Financial Group’s BeOne Medicines Ltd ONC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$104M	Buy	349,651 +45,312	+15%	+$14.7M	0.16%	96
2025 Q4	$92.5M	Sell	304,339 -38,583	-11%	-$12.6M	0.14%	107
2025 Q3	$117M	Buy	342,922 +480	+0.1%	+$146K	0.19%	84
2025 Q2	$82.9M	Buy	342,442 +68,046	+25%	+$16.7M	0.15%	117
2025 Q1	$74.7M	Sell	274,396 -21,166	-7%	-$4.95M	0.14%	124
2024 Q4	$54.6M	Buy	295,562 +8,448	+3%	+$1.73M	0.1%	177
2024 Q3	$64.5M	Buy	287,114 +25,004	+10%	+$4.5M	0.13%	163
2024 Q2	$37.4M	Buy	262,110 +11,243	+4%	+$1.73M	0.08%	235
2024 Q1	$39.2M	Buy	250,867 +85,934	+52%	+$13.8M	0.08%	227
2023 Q4	$29.7M	Buy	164,933 +34,481	+26%	+$6.24M	0.07%	251
2023 Q3	$23.5M	Buy	130,452 +15,264	+13%	+$3.02M	0.06%	256
2023 Q2	$20.5M	Buy	115,188 +8,982	+8%	+$2.07M	0.05%	294
2023 Q1	$22.9M	Buy	106,206 +3,006	+3%	+$721K	0.06%	281
2022 Q4	$22.7M	Sell	103,200 -376	-0.4%	-$69K	0.06%	281
2022 Q3	$14M	Buy	103,576 +5,804	+6%	+$997K	0.04%	348
2022 Q2	$15.8M	Buy	97,772 +4,170	+4%	+$651K	0.04%	345
2022 Q1	$17.7M	Buy	93,602 +8,967	+11%	+$1.91M	0.04%	333
2021 Q4	$22.9M	Buy	84,635 +643	+0.8%	+$217K	0.05%	295
2021 Q3	$30.5M	Buy	83,992 +4,123	+5%	+$1.35M	0.08%	238
2021 Q2	$27.4M	Buy	79,869 +6,465	+9%	+$2.14M	0.07%	252
2021 Q1	$25.6M	Sell	73,404 -8,589	-10%	-$2.84M	0.07%	249
2020 Q4	$21.2M	Buy	81,993 +2,040	+3%	+$562K	0.06%	274
2020 Q3	$22.9M	Buy	79,953 +2,336	+3%	+$549K	0.08%	243
2020 Q2	$15K	Buy	77,617 +2,982	+4%	+$485K	﹤0.01%	1503
2020 Q1	$9.19M	Buy	+74,635	New	+$11.7M	0.04%	338